Sera Prognostics, Inc. Share Price & Technical Analysis
SERA · $2.05 (+0.49%)
Healthcare / Medical Devices
$2.05
+0.49%
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of …
Price chart
Seasonality
Jun has 3 positive and 2 negative years (last 5 years shown)
-5% return in Jun, 15% avg return in past 3 year Jun month.
-33% return in 2026, 116% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -7% | -18% | -9% | -5% | 10% | -5% | – | – | – | – | – | – | -33% |
| 25 | -21% | -33% | -12% | -19% | -45% | 75% | 4% | 14% | -3% | 10% | 0% | -9% | -39% |
| 24 | 21% | 25% | 1% | 30% | -22% | -34% | 41% | -11% | 7% | 1% | -14% | 21% | 66% |
| 23 | 15% | 147% | 3% | -13% | -6% | 3% | -9% | -40% | 6% | -11% | 12% | 216% | 322% |
| 22 | 1% | -23% | -28% | -41% | -42% | 7% | 44% | -5% | -27% | -6% | -13% | -7% | -140% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation. It is also involved in the development of a pipeline of novel blood-based biomarker tests and predictive analytic products and services for pregnancy related conditions, such as time-to-birth, predictive analytics product, pregnancy risk prediction panel, preeclampsia, and fetal growth restriction. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$81.84M
P/E ratio
—
52W high
$4.09
52W low
$1.37
Volume
20,112
Beta
0.93
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹34,400
Abbott Laboratories Cede…
₹32,740
Eli Lilly And Company Ce…
₹28,720
Unitedhealth Group Inc C…
₹17,140
Elevance Health Inc
₹6,770
Frequently asked questions
- What is Sera Prognostics, Inc. share price today?
- Sera Prognostics, Inc. (SERA) last traded around $2.05 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does SERA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for SERA. Download the app for real-time alerts.
- How can I analyze Sera Prognostics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.